Dow Down 0.03% Nasdaq Up 0.33%

Incyte Corporation (INCY)

-NasdaqGS
54.16 Up 0.22(0.41%) 2:03PM EDT - Nasdaq Real Time Price
Prev Close:53.94
Open:54.22
Bid:54.12 x 300
Ask:54.21 x 100
1y Target Est:75.50
Beta:0.29
Earnings Date:Oct 29 - Nov 3 (Est.)
Day's Range:53.94 - 54.58
52wk Range:33.01 - 70.86
Volume:310,618
Avg Vol (3m):2,250,740
Market Cap:9.12B
P/E (ttm):N/A
EPS (ttm):-0.65
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Headlines

» More Headlines for INCY

Comparison

Symbol% ChgMkt Cap
INCYUp 0.41%9.12B
AMGNUp 0.46%105.84B
CELGDown 0.03%75.69B
RHHBYDown 0.30%247.67B

Key Statistics

Forward P/E (1 yr):246.18
P/S (ttm):24.45
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-14) :-0.36
Quarterly EPS Est (Sep-14) :-0.01
Mean Recommendation*:1.7
PEG Ratio (5 yr expected):-1.79

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Incyte Corporation, a biopharmaceutical company, focuses on the discovery, development, and commercialization of proprietary small molecule drugs primarily for oncology and inflammation. View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback